Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$331K Buy
13,727
+202
+1% +$5.28K 0.22% 52
2026
Q1
$380K Buy
13,525
+200
+2% +$5.33K 0.29% 51
2025
Q4
$332K Buy
13,325
+70
+0.5% +$1.76K 0.23% 55
2025
Q3
$338K Sell
13,255
-2,500
-16% -$61.7K 0.24% 54
2025
Q2
$382K Sell
15,755
-100
-0.6% -$2.33K 0.29% 48
2025
Q1
$402K Hold
15,855
0.36% 47
2024
Q4
$421K Buy
+15,855
New +$430K 0.35% 45

Other funds holding PFE

bLong Financial's PFE Position: Q2 2026 in Review

bLong Financial increased its Pfizer (PFE) stake by 1.5% in Q2 2026, buying an estimated $5.28K and bringing the position to 13,727 shares worth $331K. The position accounts for 0.22% of the portfolio, ranked #52.

bLong Financial first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $421K in Q4 2024. 2,814 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • bLong Financial held 13,727 shares of Pfizer worth $331K as of Q2 2026.
  • bLong Financial bought 202 Pfizer shares in Q2 2026, an estimated $5.28K.
  • Pfizer made up 0.22% of bLong Financial's portfolio in Q2 2026, its #52 holding.
  • bLong Financial first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • bLong Financial's Pfizer position peaked at $421K in Q4 2024.
  • 2,814 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on bLong Financial's 13F filing for Q2 2026, filed 21 Jul 2026.